Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1801253
rs1801253
0.100 GeneticVariation BEFREE Since the pivotal role of β1 adrenergic receptor (β1-AR) in HF, many publications have studied the associations between the β1-AR polymorphisms (Ser49Gly and Arg389Gly) and HF, with inconsistent results. 22815685

2012

dbSNP: rs1801253
rs1801253
0.100 GeneticVariation BEFREE We investigated whether a predefined combination of the Arg389Gly polymorphism in the adrenergic β(1) -receptor gene (ADRB1) and the Gln27Glu polymorphism in the adrenergic β(2) -receptor gene (ADRB2) could predict survival in carvedilol- and metoprolol-treated chronic heart failure (HF) patients. 21395649

2011

dbSNP: rs1801253
rs1801253
0.100 GeneticVariation BEFREE Single nucleotide polymorphisms (SNPs) within the β(1)- (Ser49Gly, Arg389Gly) and β(2)-adrenoceptor (Arg16Gly, Gln27Glu, Thr164Ile) have been associated with alterations in adrenoceptor (AR) function sensitivity in vitro and in vivo and possibly contribute to HF progression. 20803192

2010

dbSNP: rs1801253
rs1801253
0.100 GeneticVariation BEFREE One study of risk for heart failure suggested a synergistic effect of ADRB1 Arg389Gly with the insertion/deletion polymorphism in the alpha2C-adrenergic receptor gene (ADRA2C). 17496726

2007

dbSNP: rs1801253
rs1801253
0.100 GeneticVariation BEFREE We tested the hypothesis that polymorphisms at codons 389 (Arg389Gly) and 49 (Ser49Gly) of the beta(1)-adrenergic receptor would be associated with differences in initial tolerability of beta-blocker therapy in patients with heart failure. 15735607

2005

dbSNP: rs1801253
rs1801253
0.100 GeneticVariation BEFREE An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study. 12921807

2003

dbSNP: rs76992529
rs76992529
TTR
0.070 GeneticVariation BEFREE Among individuals of African or Hispanic/Latino ancestry enrolled in 2 academic medical center-based biobanks, the TTR V122I genetic variant was significantly associated with heart failure. 31821430

2019

dbSNP: rs76992529
rs76992529
TTR
0.070 GeneticVariation BEFREE This clinical algorithm may be useful for identification of ATTR V122I amyloidosis in elderly African American patients with HF. 28196196

2017

dbSNP: rs76992529
rs76992529
TTR
0.070 GeneticVariation BEFREE Patients with ATTR V122I had the worst prognosis compared with other causes of Afro-Caribbean heart failure and white patients. 27618855

2016

dbSNP: rs76992529
rs76992529
TTR
0.070 GeneticVariation BEFREE We did not detect a significant difference in mortality between V122I TTR allele carriers and noncarriers, a finding that contrasts with prior observations; however, the risk of heart failure was increased among carriers. 25551524

2015

dbSNP: rs76992529
rs76992529
TTR
0.070 GeneticVariation BEFREE It appears to be far less common than the previously described Val122Ile mutation but onset may be at an earlier age, potentially making heart transplantation a viable option should heart failure become severe. 23126592

2012

dbSNP: rs76992529
rs76992529
TTR
0.070 GeneticVariation BEFREE Transthyretin amyloidosis associated with variant V122I (ATTR V122I) is likely to be an important cause of heart failure in Afro-Caribbean populations, but the high prevalence of left ventricular hypertrophy (LVH) and lack of awareness of this genetic disorder pose diagnostic hurdles. 22795285

2012

dbSNP: rs76992529
rs76992529
TTR
0.070 GeneticVariation BEFREE After the age of 65 years (CHS), the frequencies of congestive heart failure (38% vs 15%, relative risk 2.62, P = .04) and mortality (76% vs 53%, relative risk 1.46, P = .08) were higher in V122I allele carriers than in age-, gender- and ethnically matched controls. 20435197

2010

dbSNP: rs1801252
rs1801252
0.060 GeneticVariation BEFREE The objective of this study was to determine whether ADRB1 Ser49Gly and Arg389Gly are associated with recovery of left ventricular ejection fraction (LVEF) in patients with heart failure. 30756358

2019

dbSNP: rs1799983
rs1799983
0.060 GeneticVariation BEFREE Heart failure and endothelial nitric oxide synthase G894T gene polymorphism frequency variations within ancestries. 28554876

2018

dbSNP: rs1801252
rs1801252
0.060 GeneticVariation BEFREE Data from our study suggest that the β adrenoreceptor Gly 49 allele of the β1 -adrenergic receptor Ser(49) Gly polymorphisms may increase the risk of ICD shock in patients with heart failure, independent of beta-blocker dosage. 27027728

2016

dbSNP: rs1799983
rs1799983
0.060 GeneticVariation BEFREE Homozygosity for the G allele of the eNOS G894T polymorphism was associated with worse survival in systolic HF patients, especially in those treated with nitrates. 25917853

2015

dbSNP: rs1799983
rs1799983
0.060 GeneticVariation BEFREE Endothelial nitric oxide synthase (eNOS) Glu298Asp single nucleotide polymorphism (SNP) genotype has been associated with a worse phenotype amongst patients with established heart failure and in patients with progression of their renal disease. 25612295

2015

dbSNP: rs699
rs699
AGT
0.060 GeneticVariation BEFREE The current meta-analysis suggests that M235T polymorphism might be associated with increased risk of heart failure in Caucasians. 23154270

2014

dbSNP: rs699
rs699
AGT
0.060 GeneticVariation BEFREE The pooled data showed that there was no significant associations between the AGT M235T polymorphism and HF</span> risk for TT vs. MM (OR = 1.17, 95%CI = 0.62-2.19, P = 0.635), MT vs. MM (OR = 0.97, 95%CI = 0.77-1.22, P = 0.776), MT/TT vs. MM (OR = 1.07, 95%CI = 0.67-1.69, P = 0.781), and TT vs. MM/MT (OR = 1.23, 95%CI = 0.86-1.76, P = 0.259). 24572548

2014

dbSNP: rs1799983
rs1799983
0.060 GeneticVariation BEFREE To evaluate the association between G894T GP and the prognosis of a sample of Brazilian outpatients with heart failure. 23949326

2013

dbSNP: rs1799983
rs1799983
0.060 GeneticVariation BEFREE This prospective study was designed to analyze the impact of three eNOS polymorphisms (T-786C, VNTR4a/b and Glu298Asp) and their haplotypes on the susceptibility and clinical outcomes in HF outpatients with systolic dysfunction. 22290017

2012

dbSNP: rs1801252
rs1801252
0.060 GeneticVariation BEFREE The Ser49Gly polymorphism did not impact the risk or prognosis of HF. 22815685

2012

dbSNP: rs699
rs699
AGT
0.060 GeneticVariation BEFREE To investigate a role of AGT G(-6)A and M235T genetic variants for chronic heart failure (CHF) and advanced atherosclerosis (AA), a total of 240 patients with CHF and 200 patients with AA of the Czech origin were evaluated for the study. 20945963

2011

dbSNP: rs1799983
rs1799983
0.060 GeneticVariation BEFREE Endothelial nitric oxide synthase Glu298Asp gene polymorphism in a multi-ethnical population with heart failure and controls. 20079452

2010